Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-22

FDA Approved: PEMETREXED — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira, Inc.'s original application for pemetrexed (injectable), authorizing a generic pemetrexed product with the established cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed (pemetrexed)

Snippet

ORIG AP for PEMETREXED (PEMETREXED)